Phase 4 Alzheimer's Disease Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with either mild cognitive impairment or mild Alzheimer's dementia linked to Alzheimer's disease.
- People aged between 50 and 90 years old (including those ages exactly 50 or 90).
- People whose brain scans or spinal fluid tests have confirmed the presence of a protein buildup associated with Alzheimer's disease (called amyloid).
- People whose results on a standard memory and thinking test (called the MMSE) fall between 22 and 30 out of 30.
- People whose score on a standard dementia rating scale (called the CDR) is either 0.5 or 1, indicating very mild to mild impairment.
- People who have been on the same doses of any permitted regular medications for at least four weeks before the screening appointment.
- People who are willing and able to follow all study procedures, including having blood drawn at regular intervals for safety monitoring.
- People who have signed a form giving their informed consent to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a significant brain or neurological condition other than Alzheimer's disease, such as a history of stroke or Parkinson's disease.
- People whose MRI scans show a history of bleeding in the brain, small bleeds (microbleeds), or a related condition called superficial siderosis.
- People who take blood-thinning medications that cannot be safely paused during the study.
- People who have serious ongoing health conditions, such as severe heart failure or poorly controlled diabetes, that could interfere with the study.
- People who have a known allergy or sensitivity to the study drug (Lecanemab) or any of its ingredients.
- People who are pregnant or currently breastfeeding.
- People who have taken part in another interventional clinical trial within the past 30 days.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613705790560
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Plasma Alzheimer's Biomarkers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.